Literature DB >> 2180156

5-Lipoxygenase: a rational target for therapy of inflammatory bowel disease?

J L Wallace1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2180156     DOI： 10.1016/0165-6147(90)90313-w

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  3 in total

1.  Nephrotic syndrome associated with N-hydroxyureas, inhibitors of 5-lipoxygenase.

Authors:  N G Read; P J Astbury; G O Evans; D A Goodwin; A Rowlands
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

2.  Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.

Authors:  R A Patrick; P A Peters; A C Issekutz
Journal:  Agents Actions       Date:  1993-11

Review 3.  New developments in the pharmacotherapy of inflammatory bowel disease.

Authors:  J W Harting
Journal:  Pharm Weekbl Sci       Date:  1992-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.